Pro Share Advisors LLC Cytokinetics Inc Transaction History
Pro Share Advisors LLC
- $42.5 Billion
- Q4 2024
A detailed history of Pro Share Advisors LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 43,299 shares of CYTK stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,299
Previous 33,679
28.56%
Holding current value
$1.9 Million
Previous $1.78 Million
14.51%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$645 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$524 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$473 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$347 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$271 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.14B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...